Combining two drugs with two CDs for formulation of a dry powder for inhalation
Dry powders for inhalation are evolving to address the challenge of maximizing lung deposition, with growing interest in carrier-free formulations
A forum for researchers, students and applicants in the field of cyclodextrin technology
Dry powders for inhalation are evolving to address the challenge of maximizing lung deposition, with growing interest in carrier-free formulations
Pulmonary infections (PIs) are contributing as a significant cause of mortality across the world. The clinical applications of a variety
In this study, Que-β-cyclodextrin inclusion complexes (Que-β-CD) were prepared using the supercritical antisolvent (SAS) process with supercritical carbon dioxide (SCCO2)